Chaga (Inonotus obliquus)
>10× potency gap
Wild-harvested sclerotium products outperformed mycelium-based alternatives across every bioactive measure tested in a 2025 comparative analysis of commercial chaga supplements.
Windsor et al., International Journal of Molecular Sciences, 2025
8 triterpenoids
identified in wild sclerotium including betulinic acid
Melanin polymer
is the primary driver of chaga's antioxidant score
~90% birch wood
the sclerotium's composition by mass
Windsor et al., International Journal of Molecular Sciences, 2025
View as image ↗The black mass on the side of a birch tree that gets harvested for chaga supplements is roughly 90% degraded birch wood.[1] The fungal component is a minority of what you are actually buying. And the structure itself, what mycologists call a chaga sclerotium, is nothing like a mushroom in the biological sense. The Inonotus obliquus fungus does produce a true fruiting body, but it forms hidden beneath bark and is almost never observed, let alone harvested.
That distinction matters more than it sounds. What makes the chaga sclerotium chemically special is precisely where it spends its life: pressed against birch bark in cold northern forests for a decade or more, slowly absorbing compounds the tree produces. Betulinic acid and betulin, triterpenoids found in birch bark, end up in the sclerotium at levels found nowhere else in the fungal kingdom.[3] Lab-grown chaga mycelium, without a birch tree to grow on, never accumulates them. That is the practical consequence of the biology.
For a complete overview of chaga's research and bioactive profile, see What Is Chaga Mushroom? The King of Medicinal Mushrooms. This article focuses specifically on the sclerotium: what it is, why the birch relationship matters chemically, and what that means for the supplements in the market.
Key Takeaways
- A chaga sclerotium is roughly 90% degraded birch wood and 10% fungal tissue; it is not a mushroom, not a fruiting body, and not equivalent to mycelium (Fordjour et al., Frontiers in Pharmacology, 2023)
- Inonotus obliquus does produce a true fruiting body, but it forms hidden under birch bark and is almost never seen in practice
- Betulinic acid and betulin, chaga's most studied triterpenoids, come from the birch tree rather than the fungus itself; mycelium-based products completely lack these compounds (Kim et al., Molecules, 2020)
- The black exterior of chaga is melanin, a polymer the fungus produces as UV protection; this melanin fraction is the primary driver of chaga's extreme antioxidant capacity, not the polysaccharides (Burmasova et al., Biomolecules, 2019)
- A 2025 analysis found wild-harvested sclerotium products outperformed mycelium-based products on every bioactive measure, with greater than tenfold variation across commercial chaga supplements (Windsor et al., 2025)
- Chaga's full compound profile, including sterols, triterpenoids, polysaccharides, and melanin, is only intact in wild-harvested sclerotium from birch trees (Glamočlija et al., Journal of Ethnopharmacology, 2015)
What a Chaga Sclerotium Actually Is (and Why the Real Fruiting Body Is Invisible)
A fruiting body is the reproductive structure a fungus makes to release spores. The cap, the gills, the stem. That is not what chaga is.
Chaga is a sclerotium: a hardened, irregular mass that Inonotus obliquus produces when it colonizes a birch tree. Sclerotia are dense, dormant storage structures, compacted fungal tissue mixed with organic matter from the host. In chaga's case, the host material is birch wood, and the proportions are striking. The sclerotium growing on the tree's exterior is composed mostly of degraded birch wood interwoven with fungal mycelium, with the mycelium making up only about 10% of the total mass.[1]
The definition that answers the search question directly: Chaga is a sterile sclerotium, a hardened mass of fungal mycelium (roughly 10%) mixed with degraded birch wood (roughly 90%). The true fruiting body of Inonotus obliquus forms hidden under the bark of a dying or recently dead birch tree, and is rarely observed. The black exterior is melanin, not bark.
The real fruiting body of Inonotus obliquus is a separate structure entirely. It forms in the cambium layer beneath the bark, only erupting outward as the tree approaches death or just after. This structure is flat and crust-like, with irregular pores rather than gills, classified as resupinate. It releases spores and then disappears. Most people who work with chaga their entire lives never see it. Sustainable harvesting practices depend on leaving part of the sclerotium intact so these hidden fruiting bodies can still complete the reproductive cycle before the host tree dies.[1]
Traditional Siberian and Russian use, documented across centuries, was always focused on the sclerotium. Indigenous Khanty and other northern groups boiled it into a dark tea, used it as a coffee substitute during scarcities, and credited it with anti-cancer and digestive properties.[2] The fruiting body was never the target, in part because it is invisible until the tree is already dying, and in part because the sclerotium is where the chemistry concentrates.
Scientifically, the sclerotium is classified as a sterile conk. "Sterile" means it produces no spores. "Conk" refers to its hard, woody growth form on tree bark. It is parasitic in the sense that it draws nutrients from the birch as the fungus slowly kills its host over 10 to 80 years, accumulating compounds from both organisms the entire time.
Why Growing on Birch Is What Makes Chaga Chemically Unique
Chaga can colonize other trees occasionally, including alder, beech, and hornbeam. But the birch-sourced sclerotium is what gets commercially harvested and what virtually all research has studied. The reason comes down to compounds in birch bark that the fungus cannot make for itself.
Birch trees produce betulin in their outer bark as part of their own defense chemistry. This compound, along with betulinic acid, is not made by the Inonotus obliquus fungus. The sclerotium, growing pressed against birch bark for years, absorbs betulin and converts it enzymatically into related sterols including inotodiol and lanosterol.[3]
A 2020 analysis by Kim and colleagues identified eight major triterpenoids in wild chaga sclerotia, including betulin, betulinic acid, inotodiol, and lanosterol, and confirmed these were of birch origin rather than fungal biosynthesis.[3] Betulinic acid, in particular, showed the highest anti-proliferative activity against cancer cell lines of any compound in the study. It is among the most studied compounds in the chaga literature.
None of these triterpenoids are present in chaga mycelium grown without birch trees. There is no metabolic pathway in the fungus to produce them from scratch. They have to be absorbed from the host bark. A product labeled "chaga" that uses mycelium grown in oat or rice substrate has zero of these compounds. It may contain beta-glucans and some polysaccharides from the mycelium cell wall, but the birch-origin triterpenoid fraction is simply absent.
This is why the sclerotium is not just a "stronger version" of chaga mycelium. It is a categorically different compound profile, not a matter of degree.
For a detailed look at what betulinic acid does at the cellular level, see Betulinic Acid from Chaga: Anti-Cancer Mechanisms.
The Black Exterior Is the Antioxidant: Chaga's Melanin Story
One of the more counterintuitive facts about chaga is that the compound responsible for its distinctive appearance is also the primary source of its antioxidant activity.
Chaga's black exterior is melanin, a polymer the fungus synthesizes as protection against ultraviolet radiation and oxidative damage from the environment. Melanin is found in human skin and in many other organisms for the same reason: absorbing UV and neutralizing reactive oxygen species before they damage cellular structures.
In chaga, the melanin accumulation is extraordinary compared to most other fungi. A 2019 study by Burmasova and colleagues specifically isolated and tested chaga's melanin fraction and found two things: it showed strong antioxidant activity across multiple assay methods, and it also showed bifidogenic effects, meaning it selectively promoted the growth of beneficial Bifidobacterium species in gut microbiome experiments.[5] The antioxidant performance came from the melanin itself, not from the polysaccharide or phenolic fractions tested separately.
This has a practical implication. When people cite chaga's ORAC score (among the highest measured for any substance), the mechanism behind that extreme number is primarily the melanin polymer, not the polysaccharides that most people associate with medicinal mushroom benefits.[5] Products that lack intact black sclerotium tissue, or that use pale mycelium biomass without the dark melanin layer, have a fundamentally different antioxidant profile.
The ecological logic is straightforward. A slow-growing sclerotium on the exposed surface of a birch tree in Siberia faces intense UV exposure, especially in winter when the low sun angle creates long daily exposures at high reflectance from snow cover. Extreme melanin accumulation is the fungus's solution to surviving decades in those conditions. The antioxidant chemistry is the organism protecting itself from its environment, not something it produces for our benefit.
The Four Compound Classes in the Sclerotium, and What Each Does
The chaga sclerotium contains four distinct classes of bioactive compounds with different chemistry, different solubility, and different proposed functions. Understanding each class matters for understanding what a specific product actually contains.
Polysaccharides (beta-glucans). The structural sugars of the fungal cell wall, including beta-1,3/1,6-glucans. These are the compounds most commonly associated with immune modulation in medicinal mushrooms generally. Beta-glucans are water-soluble, and hot-water extraction releases them reliably from sclerotium tissue.[4] Mycelium-based products can contain these, though concentrations are often diluted by grain substrate starch.
Melanin. The high-molecular-weight polymer discussed above, water-soluble, concentrated in the dark exterior of the sclerotium, and the primary driver of the extreme antioxidant capacity.[5] The melanin fraction also contains phenolic side-chains and gives chaga tea its characteristic deep brown color.
Triterpenoids and sterols. Inotodiol, lanosterol, betulin, betulinic acid, and related compounds. Alcohol-soluble, not released by hot water alone. This is why dual extraction is required to capture the full chaga profile: water pulls polysaccharides and melanin, while ethanol pulls the triterpenoids. A 2015 characterization by Glamočlija and colleagues identified the complete sterol and triterpenoid profile of the sclerotium and confirmed both antimicrobial and antioxidant activity from these fractions across multiple bioassays.[4]
Phenolic compounds. Smaller antioxidant molecules including inonoblin A, B, and C, plus other hydroxylated aromatic compounds. These contribute to total antioxidant capacity alongside melanin and are distinct compounds with their own free radical scavenging activity.[4]
A wild-harvested sclerotium from birch contains all four compound classes. A mycelium-based product contains primarily polysaccharides, with none of the triterpenoids and typically far less melanin. The difference is not a formulation decision; it is a consequence of the biology.
For a detailed look at how extraction methods determine which compound classes survive into the final product, see Dual Extraction: Why It Matters for Full-Spectrum Mushroom Products.
The Compound Gap Between Sclerotium and Mycelium-Based Products
The supplement industry uses the word "chaga" to describe two very different things, and most labels do not distinguish between them.
Wild-harvested sclerotium from birch trees contains the complete four-class compound profile described above. Mycelium cultivated in substrate, the cheaper and more scalable alternative, does not. When chaga mycelium grows on oats or brown rice, it cannot absorb birch-origin compounds because there is no birch tree. The entire triterpenoid fraction (betulin, betulinic acid, inotodiol) simply does not form.[3]
Beta-glucan content may also be diluted by starch from the grain substrate. This is a documented problem across the medicinal mushroom supplement market generally. A 2012 study by Lo and colleagues compared fruiting bodies and mycelia across multiple culinary-medicinal mushroom species and found systematic differences in beta-glucan, ergosterol, and antioxidant content between the two source types.[6] The pattern was consistent: fruiting bodies outperformed mycelium across all bioactive markers measured.
In chaga specifically, the problem is compounded by an unusual factor: the sclerotium is not a fruiting body. It is a third structure, distinct from both fruiting body and mycelium, and it grows in a way that no other commercially important medicinal mushroom does. The comparison is not wild chaga versus cultivated chaga. It is wild sclerotium with birch-absorbed triterpenoids versus mycelium with none of them. That is a categorical difference, not a degree-of-difference.
For a direct comparison of what wild harvesting means for product quality, see Wild vs. Cultivated Chaga: Does It Matter?.
What a 2025 Study Found When It Tested Commercial Chaga Supplements
The theoretical argument above received direct empirical support in 2025.
Windsor and colleagues analyzed commercial chaga dietary supplements using multiple complementary analytical techniques, comparing beta-glucan content, polyphenol concentration, antioxidant activity, and triterpenoid profiles across a range of products.[7] Wild-harvested sclerotium products consistently outperformed mycelium-based products on every bioactive measure tested. The variation between the best and worst products in the analysis exceeded tenfold.[7]
The study also found mislabeling in several commercial products. Cases where the label did not accurately represent whether the source material was sclerotium or mycelium, or where the stated bioactive content did not match what was measured analytically.[7] This is a regulatory gap. The FDA does not require chaga supplements to specify whether they use wild sclerotium or lab-grown mycelium, and there is no standardized requirement for bioactive content verification.
What the label should say: "Wild-harvested Chaga sclerotium" is the specific source designation to look for. "Chaga fruiting body" is technically incorrect (chaga does not produce a commercially harvestable fruiting body) but in practice usually refers to wild sclerotium. "Chaga mycelium" or "myceliated grain" means no birch-origin triterpenoids are present. Third-party testing for beta-glucan content adds verification; triterpenoid panel testing is less common but more informative for this particular species.
No label standard currently guarantees the full compound profile. But wild-harvest sclerotium source, combined with dual extraction and third-party beta-glucan verification, represents the current ceiling on confirmed quality in the market.
The Bottom Line
What the supplement industry calls "chaga" ranges from wild birch-parasitizing sclerotia with four distinct compound classes to lab-grown mycelium lacking the birch-origin triterpenoids many buyers are specifically seeking. The biology of the sclerotium, not a mushroom but a parasitic conk that spends decades absorbing compounds from its host tree, is the direct cause of that gap. A 2025 comparative supplement analysis confirmed this gap is real, measurable, and greater than tenfold across commercial products.
Frequently Asked Questions
Sources & References
- 1. Source details for this reference are not yet available.
- 2. Source details for this reference are not yet available.
- 3. Source details for this reference are not yet available.
- 4. Source details for this reference are not yet available.
- 5. Source details for this reference are not yet available.
- 6. Source details for this reference are not yet available.
- 7. Source details for this reference are not yet available.